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ABSTRACT 
Currently, research on biomaterials must meet and demonstrate a set of therapeutic competence to level many health 
problems. The objective of our work is to normalize the technique of implantation of the biomaterial (carbonated 
hydroxyapatite: HAC). Three modes subcutaneous implantation was carried out. This technique consists to select the 
most tolerated by the body without toxicity. Thus, we have applied our biomaterial (HAC) in pellet form under pressure, 
under pressure sintering pellets and capsules for two weeks. Our results showed that the capsule did not disturb and 
mainted the equilibrium and balance or ferric ion phosphate balance, prevent against the toxicity of hepato-renal system 
by comparison with the pellets. These results demonstrated the tolerance, the biocompatibility and the integrity of apatite 
administered in capsule. 
Indexing terms/Keywords 
Biocompatibility; Carbonated hydroxyapatite; Oxidative stress; Subcutaneous implantation. 
Academic Discipline And Sub-Disciplines 
Biomaterials 
SUBJECT  CLASSIFICATION 
Biology Subject Classification 
TYPE (METHOD/APPROACH) 
Experimental study-implantation. 
 
 
 
 
 
 
 
 
 
 
 
 
Council for Innovative Research 
Peer Review Research Publishing System 
Journal: Journal of Advances in Chemistry 
Vol. 8, No. 2 
editor@cirjac.com 
www.jac.cirworld.com, member.cirworld.com 
ISSN 2321-807X 
1613 | P a g e                                                         M a r c h  2 6 ,  2 0 1 4  
1. Introduction  
Biomaterials cover many domains of applications such as ophthalmology, orthopedic surgery, cardiovascular, dentistry, 
urology, endocrinology, plastic surgery ... etc). Materials science oriented multidisciplinary biomedical and requires close 
collaborations between experts in various fields: chemist, biologists and Surgeons. 
Among bioceramics, Hydroxyapatite (Ca10 (PO4)6 (OH)2) is known for its physical and chemical properties very similar to 
those of calcified tissues (bone, dentine ....). It can be produced from coral [1-2], the shell [2-3], eggshell [2,4-6] and also 
from body fluids [2,7]. It is non-toxic, non-inflammatory, non-immunological and bioactive [8-9]. As well, the Hydroxyapatite 
(HA) is a good candidate for bone substitution because of its chemical and structural similarity with bone mineral [10-11]. 
In addition, this biomaterial through a crystalline phase of calcium phosphate minerals found naturally in bone, has shown 
tremendous promise as a graft material [12]. Our biomaterial (carbonated hydroxyapatite) so presents a biocompatibility, 
bioactivity and bioresorbable properties [13-17]. 
But, this material has several drawbacks, on the one hand, it is osteoconductive but not osteoinductive, on the other hand, 
the mechanical behavior of these materials remains very fragile. 
In previous work [9], we used a carbonated hydroxyapatite (HAC) biomaterial type. The implantation of HAC "in vivo" was 
formed in pellet form at the bone of rabbits. The results, obtained by exploration physiological and physico-chemical 
properties of bone after implantation, showed that the implant is not toxic secondary effects on the body on the one part 
and permits a good consolidation of the bone without oxidative stress in the other part.  
To better see the influence of the purity of the biomaterial HAC on the one hand and the mode of implantation on the other 
hand on the biological and physicochemical parameters on a model animal (rat strain "Wister"), we studied in the present 
work a biomaterial type 80% of HAC and 20% β-TCP (β - tricalcium phosphate) as a subcutaneous implant. 
The objective of this study is to select the best method to implant our biomaterial in rat, without toxicity and with a good 
tolerance by the organism. 
So, three types of subcutaneous implants were applied. Thus, in this work, the three methods to apply our biomaterial 
(Hydroxyapatite) pellets under pressure, under pressure sintering pellets and capsules implanted in rats strain "Wistar" 
were used. Our study is based therefore on the physiological effects (oxidative stress, hepatorenal toxicity, balance iron 
and phosphocalcic) and the physico-chemical characterization through diagrams analysis (X-ray diffraction and infrared 
spectroscopy) of these three types of implants. 
2. Material and Methods 
2.1. Synthesis of the biomaterial  
The powder of the carbonated hydroxyapatite (HAC) was prepared by the method of double decomposition (wet), which 
consists in adding a solution of calcium nitrate to a solution of ammonium phosphate in well-defined operating conditions. 
The product obtained after filtration of the solution, is subjected to calcination at 400 ° C. The powder thus obtained was 
transformed into implant in three physical forms: 
- Pellet formed under pressure (PP): 300 mg powder of HAC was milled during 5 minutes and then compacted under a 
pressure of 8 bars during 15 minutes. 
- Pellet formed under sintering and pressure (PPS): 300 mg powder of HAC was ground during 5 minutes and then 
compacted under a pressure of 8 bars during 15 minutes and then was put in the oven with a program for 6 hours in 1000° 
C. 
- Capsule (Cap): 300 mg powder of HAC was stored into capsule which was purchased from local pharmacy. 
2.2. Animals and treatments 
The assays of the present study were conducted on adult male Wistar rats, weighting 240 ±10 g, which were obtained 
from the local Central Pharmacy, Tunisia. All rats were kept in an environmentally controlled breeding room (temperature: 
20 ± 2°C; humidity: 60 ± 5%; 12h dark/light cycle). They had standard diets and free access to tap water. The 
experimental protocols were conducted in accordance with the guide for the care and use of laboratory animals issued by 
the University of Sfax, Tunisia, and approved by the Committee of Animal Ethics. Animals were anesthetized 
subcutaneously by injection of chlorhydrate lidocaine (10 mg/Kg body weight). After surgical incision, different physical 
forms of HAC (300 mg each sample) were implanted in rats. The experimental rats were divided into 4 groups of eight 
animals each as follows: 
Group 1: control rats, considered as referent non-implanted rats. (C) 
Group 2: operated rats implanted with HAC as PP form during 2 weeks. (PP) 
Group 3: operated rats implanted with HAC as PPS form during 2 weeks. (PPS) 
Group 4: operated rats implanted with HAC as capsule form during 2 weeks. (Cap) 
The animals were supervised daily to detect the presence of the implant. Two weeks later, the rats were sacrificed by 
decapitation, and their trunk blood was collected. The serum was prepared by centrifugation (1500×g, 15min, 4°C), frozen 
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and stored at -20°C until analysis. The kidney and liver were removed and cleaned of fat. Samples of femoral bone were 
collected from each group of animal for further physicochemical analysis. All samples were stored at -80°C until used.  
2.3. Oxidative stress measurements 
The lipid peroxidation in the liver and kidneys of control and all treated groups of animals was measured by the 
quantification of thiobarbituric acid-reactive substances (TBARS) [18] and Conjugated Dienes (CD) [19]. The activity of 
superoxide dismutase (SOD) was assayed by the spectrophotometric method [20]. The glutathione peroxidase (GPx) 
activity was measured by the method described by Pagila and Valentine [21]. The catalase (Cat) was assayed 
colorimetrically at 240 nm and expressed as moles of H2O2 consumed per minute per milligram of protein [22]. The level 
of total protein was determined by the method of Lowry et al. using bovine serum albumin as the standard at 660 nm [23]. 
2.4.Biochemical analysis 
The serum electrolytes, calcium, phosphorus and iron concentrations were determined by an automatic ion analyzer (IA 
300, Japan). Serum levels of Aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl 
transpeptidase (GGT) activities and creatinine rate were measured in frozen aliquots of serum by standardized enzymatic 
procedures using commercial  kits from (Biolabo, France) on an automatic biochemistry analyzer (Vitalab Flexor E, USA) 
at the clinic pathological laboratory of Sidi Bouzid Hospital.  
2.5.Physicochemical analysis 
The samples of powder and bone were characterized by X Ray-Diffraction (XRD) and Infrared Absorption Spectrometry 
(IR). The IR spectra in the range 4000-400 cm-1 were recorded as KBr pellets with a JASKO FT/IR 420 spectrometer.  
The XRD pattern of powder and bone simples was measured on a Seifert XRD 3000 TT diffractometer controlled by an 
IBM PC microcomputer. Measurements were made using a step-scanning technique at fixed time intervals, the calculation 
of the crystallographic parameters and the mesh volume apatitic of powder and bone were realized using the program 
CELREF. 
2.6. Statistical analysis 
Data are presented as means ± standard deviation (SD). Statistical significance was assessed by the Fisher test. *P < 
0.05 was considered statistically significant. 
3.Results 
3.1. Physiological properties 
3.1.1. Effect of HAC implantation on TBARS and CD in liver and kidney of experimental animal 
As shown in Fig. 1 and 2, a significant increase (44% and 29%) of TBARS and (23% and 40%) of CD levels was observed 
in liver of PP and PPS rats respectively in comparison with the control. Remembered that these markers (CD and TBARS) 
are indicators of lipid peroxidation. This was probably related to generation of free radicals which caused the oxidative 
damage to the tissues. At the same time an increase in TBARS and CD levels in the kidney respectively of PP (by about 
21% and 25% ) and PPS (by about 22% and 28% ) compared to the controls was obtained (Fig.1 and 2). Whereas hepatic 
and renal, capsule apatite induces a significant decrease of TBARS and CD compared to treated PP and PPS. We can 
therefore conclude that the apatite administered in capsule is more tolerated by organism and has no hepato-renal stress.    
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3.1.2. Effect of HAC implantation on antioxidant enzymes (SOD, Cat and GPx) in liver and kidney of experimental 
animal 
Activities of SOD, Cat and GPx, were found to be much reduced in liver and kidney of PP and PPS rats as compared to 
control values (Fig. 3-5). These changes could worsen the oxidative stress by allowing an accumulation of free radicals. In 
rats implanted capsule, there was no significant change in the activity of these enzymes, as compared to controls (Fig. 3-
5). While rats implanted with apatite capsule showed improved antioxidant activity of this enzyme in comparison to groups 
of rats treated with pellets (PP and PPS). 
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3.1.3. Effect of HAC implantation on the ionic and serum phosphocalcic balance 
Our study (Table 1) shows that serum electrolytes (Na+, K+ and Cl-) and iron show no significant change (P > 0.05) in the 
group of rats implanted with the capsule in comparison with the control group. Conversely, groups of rats (PP) and (PPS) 
showed a significant variation (P < 0.05) in serum Na+ and iron compared with the control group. For serum calcium, the 
group implanted with the capsule (Cap) shows stability compared to the control, by cons, the groups implanted with the 
pellets (PP and PPS) show a significant decrease. It seems that the capsule is better tolerated by the body, it does not 
disturb the equilibrium ferric ion and phosphocalcic. 
 
Table 1. Biochemical variation in different lots of rats 
Groups 
Parameters 
C PP PPS Cap 
 
THE 
ELECTROLYTES 
(meq/l) 
Na
+ 
134,73 ± 0,64 
 
135,60 ± 0,49 
(*) 
 
132,37 ± 1,76 
(*) 
135,32 ± 1,32 
 
K
+ 
5,30 ± 0,31 
 
5,49 ± 0,31 
 
5,16 ± 0,53 
 
5,28 ± 0,42 
 
Cl
- 
105,86 ± 0,72 
 
106,86 ± 1,15 
 
104,85 ± 1,73 
 
107,97 ± 1,07 
 
IRON 
(µmol/l) 
12,33 ± 2,08 
 
10.00 ± 0,81 
(*) 
10.00 ± 0,81 
(*) 
12.00 ± 0,81 
 
CALCIUM 
(mmol/l ) 
2,90 ± 0,03 
 
2,76 ± 0,05 
(*) 
2,83 ± 0,04 
(*) 
2,86 ± 0,04 
 
PHOSPHORUS 
(mmol/l) 
2,69 ± 0,23 
 
2,57 ± 0,12 
 
2,66 ± 0,20 
 
2,65 ± 0,37 
 
Data represent mean ± standard deviation to the mean value of controls. * Significant as compared with control rats. 
 
3.1.4. Effect of HAC implantation on serum parameters of hepatic and renal toxicity 
This study showed a significant change for the level of serum creatinine in the groups implanted with pellets (PP and PPS) 
compared to controls. But this level has no significant change for groups implanted with capsule (Cap) and this compared 
to controls. Apatite administered in capsule does not disrupt therefore renal activity. 
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On serum indices of liver toxicity, there is an increase in AST and GGT serum for the treatment groups (PP and PPS) 
compared to the control group. In contrast, rats treated with the capsule showed a reduction in the level of these two 
indices compared to treated groups (PP) and (PPS). 
The PAL serum significantly increased the range of 19.22% and 20.31% respectively for the treated groups (PP and PPS) 
compared to control rats, conversely, these rates decreased remarkably in the group implanted with the capsule, and this 
in comparison groups (PP) and (PPS) which explains the protective effect of apatite implanted capsule form against 
hepatotoxicity (Table 2). 
 
Table 2: Change in serum parameters of hepatic and renal toxicity in different lots of rats 
               Groups 
Parameters 
C PP PPS Cap 
CREATININE 
(µmol/l) 
35,43 ± 1,35 
 
39,42 ± 2.87 
(*) 
32,73 ± 0,35 
(*) 
35,83 ± 1,24 
 
AST 
(UI/L) 
55 .00 ± 2,82 
 
59.00 ± 1,73 
 
66,50 ± 9,84 
 
55,66 ± 4,61 
 
GGT 
(UI/L) 
2,33 ± 0,57 
 
3,75 ± 0,95 
(*) 
3,50 ± 0,57 
(*)  
2,75 ± 0,43 
(*) 
PAL 
(UI/L) 
652,66 ±11,59 
 
808.00 ± 77,09 
(*) 
819.00 ± 45,25 
(*) 
576,50± 37,47 
(*) 
 
Data represent mean ± standard deviation to the mean value of controls. * Significant as compared with control rats. 
 
3.2. Physico-chemical properties 
The purpose of a physico-chemical characterization of our apatite biomaterial and cohabitation at the implantation site 
often we use two analytical techniques. The best known are infrared spectroscopy and X-ray diffraction. Indeed, these 
methods are used to determine of the one part, the nature of certain exchange ions from the body with the network 
apatite. On the other part, the detection of the integration of this implant (HAC). 
3.2.1. Study of hydroxyapatite before and after implantation 
3.2.1.1. X-ray diffraction 
Obtained results by X-ray diffraction (Fig. 6-9) of not implanted biomaterial used show the presence of two phases: apatite 
phase and β-TCP phase. We tried to follow the evolution of only apatite phase during implantation. The strongest lines are 
indexed in the hexagonal system with space group P63 / m. From the 2θ values of lines and their Miller indices hkl, the 
program CELREF was used. The crystallographic parameters a, b, c and cell volume apatite before implantation were 
calculated. After implantation of the biomaterial that exists in three physical forms (PP, PPS and Cap), we observed the 
movement of certain lines such as the strongest lines of Miller indices hkl: 200, 002, 211, 300 and 222. To better see 
these displacements, we use the calculation of crystallographic parameters (a, b and c) and the cell volume (Table III). We 
find in general significant variations in these parameters, except that the implants are in capsule form (Cap) and pellet 
(PPS) were the most changed from one form of biomaterial (PP). We thus demonstrate the high reactivity of the HA as 
capsule (Cap) and pellet (PPS) with the organization. To distinguish between these two types of biomaterials we use 
infrared technical. 
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3.2.1.2. Infrared spectroscopy of compound 
Infrared spectroscopic results, for samples of the non-implanted HAC and those located in different forms: pellet pressure 
(PP), pellet pressure and sintering (PPS) and capsule (Cap) are illustrated in Figs .10-13. 
The product used, according to the infrared spectrum, is slightly carbonated hydroxyapatite of the majority of type B and 
the rest is Type A. This is testified by the presence of four vibration modes of the phosphate group observed to: 1088.23, 
983.24, 603.06 and 473.28 cm-1. Thus, two modes of vibration that bundling CO32- observed at 1447.97 and 858.08 cm-
1. Finally, we note the presence of two modes υs and υl related to OH- group and are observed respectively at 631.67 and 
3570.53 cm-1. It should be noted the presence of even the IR spectrum two bands observed at 724.78 and 3214.05 cm-1 
which are attributed from the literature [14]  respectively υs vibration modes of OH- and υl  adjacent groups carbonates 
CO3 2-.  Hence, the existence of a small quantity of carbonate type A is confirmed. We note also the presence of some 
shoulders observed near the modes of vibration of the phosphate groups, at 1072.39, 962.26, 586.98 and 562.22 cm-1, 
which is probably attributed to the vibration modes of the PO4 3- groups to a second phase which corresponds to the non 
apatitic β-TCP. 
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The spectra of the apatite located in different physical forms (PP, PPS and Cap) show clearly the presence of different 
modes of vibration observed at hydroxyapatite implantation but before we can high light displacement of these bands and 
the disappearance of others. We also note the disappearance of the bands corresponding mainly to β-TCP because it is 
more absorbable than apatite phase. Indeed, these spectra mount the capsule undergoes further change and decline of 
the bands in the case of pellets. The form of the implant so the more resorbed and more bioactive form is the capsule.  
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3.2.2. Study of bone before and after implantation 
3.2.2.1. The X-ray diffraction 
The analysis of X-ray diagrams, performed on bone tranches not calcined in the case of different implants (C, PP, PPS 
and Cap) shows the presence of the lines large overlapping reflecting the presence of organic matter. The purpose of the 
one part is to improve the crystallization of the sample and on the other part the power of the resolution of the spectrum, 
we have calcined our bone samples at 400○C. The first results led to the elimination of the organic phase but the 
crystallization was not too improved. To do this we calcined bones at 600○C, the diffractograms presented in figures 14-17 
show much finer lines. In addition, they showed the presence of a single phase pure apatite. We note that all the samples 
control and implanted have practically the same types of lines (Miller index) except that their positions 2θ and their 
intensities different from sample to another. This encouraged us to calculate the cell parameters and the cell volume 
apatite using the program "CELREF" (Table 4). We note that these parameters and the cell volume of apatite samples 
implanted rats vary in comparison to those of control rat bone. These variations observed before and after implantation 
show that there is good interaction between the implant and the bone but that is manifested by an ion exchange important 
bone to the implant. In addition, we note that the capsule is the implant showed more bioreactivity than in the case of 
pellets. 
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3.2.2.2.The Infrared spectroscopy 
The study by infrared spectroscopy shows that the spectra of bone samples calcined up to 600○C have an apatite 
structure. Indeed, these spectra show also the existence, in addition to vibration bands related groups PO4 3 -, vibration 
modes bundling CO3 2 - observed at 1462.99, 1417.36 and 872.18 cm-1. In addition, we note the presence of two modes 
υs and υl related to OH- group and are observed respectively at 630.13 and 3569.23 cm-1. It should be noted the 
presence of even the IR spectrum of a single band observed at 3439.38 cm-1 is attributed to the vibration mode υl OH- 
ions adjacent the carbonate group CO3 2 -. Hence, the existence of a small quantity of carbonate type A. We also note 
that spectra of figures 18-21 of the bones of rats implanted groups showed the same except that their different modes of 
vibration. This proves that the mechanisms of the exchanges between the biomaterial used and the bone is totally normal 
and natural. 
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4. Discussion 
The vast majority of epidemiological studies indicate that there is a strong association between alteration of the antioxidant 
defenses and increased markers of oxidation [24]. Indeed, the conduct of various physiological mechanisms are still  not 
generators of a state of oxidative stress that when the production of free radicals is important. Our results on the oxidative 
stress show that the stress is not appeared in implanted rats by a capsule apatite and without any significant change in the 
concentration of hepatic and renal of markers of lipidic peroxidation (TBARS and CD) and activities of SOD, GPx and Cat. 
The fact, we conclude that our implantation technique by the capsule (Cap) has no deleterious effect on the body by 
inducing lipid peroxidation processes in acid polyunsaturated fatty acids of membrane lipoproteins. It shows thus that 
although there free radical production at the beginning of the treatment period or postoperative period, the rats of group 
Cap, by their antioxidant reserves, were able to fight and finally return their status homeostatsique. We have shown in 
previous work [25] that the HA does not induce an imbalance of the oxidative balance. Our study shows that the HAC 
pellet form PP and PPS implanted subcutaneous ventral has stressful effects to the body. In addition, previous work [9], 
showed that the use of HA in the form of pellet, such as bone grafting, may increase the stability of the implant, lead to 
accelerate bone regeneration and facilitate the healing process without problems immunogenic. However, the efficacy of 
biomaterial depends on one hand of its physico-chemical and biological and on second hand its mechanical environment 
where it is located.  
Our results showed that the capsule is better tolerated by the body because it does not disturb the equilibrium ferric ion 
and calcium phosphate because the HAC powder in the capsule is more bioresorbable than the pellets due to its stability 
exchange ionic.  
The bioresorbable phenomenon is dependent on the physico-chemical characteristics of materials. This is important: It will 
determine the speed when the material will be degraded “in vivo” by the phenomena of spontaneous dissolution. The 
dissolution speed of ceramics can be modified by various factors such as crystallite size and porosity of the material [26]. 
In addition, our study is in agreement with the earlier work of Mallek et al. 2005 which showed that the HA is among 
phophocalcic biomaterials that have no negative impact on the phosphocalcic homeostasis and on the mineral 
composition. 
In addition, the cytotoxic potential of biomaterials is considered one of the principal parameters to evaluate their 
biocompatibility. Our results showed that the apatite administered in capsule does not disturb liver function or renal 
because our biomaterial (HAC) is widely used because of its biocompatibility and bioactivity [27] in a medical field. 
However, the pellets cause liver and kidney alterations due to temperature and compaction because they affect the 
hardness, density, grain size, mesh size and porosity of our product. In addition, work [28] showed that the density of the 
HAC is increasing for very high sintering temperatures. In addition, other studies show that in the case of ceramics 
phosphocalcic microporosity is also inversely correlated with the sintering temperature: as the sintering temperature is low, 
the microporosity increases [29]. It has been suggested that these micropores were likely to play a role at many levels: the 
increasing of specific surface area materials, roughness and resorption as well as the creating of microenvironment inside 
these pores. These various parameters, associated with the reactivity of the material, could have an influence on the 
bioactivity of the material or on its adsorption capacity [30-31] All these results were confirmed by physico-chemical study 
(DRX and IR), which has shown that the mode of the implant capsule is better than the pellet form. In fact, according to 
the results of DRX, the differences of the cell volume between HAC unimplemented one hand and those implanted on the 
other hand showed that the Cap and the PPS have undergone more modification than in the case of PP. This shows that 
the physical aspect of the implant plays a very important role in ion exchange with the biological environment (El feki and 
al. 1991). Moreover, the IR spectra of the apatite implanted show that the capsule is the most bioactive implant, as is 
testified by the movement of many bands. This is probably due to the physical aspect of the implant which is a non-
compacted powder. Because why we have chosen a implant for the treatment of rats is the capsule type. The 
diffractograms bones of rats implanted with pellets types of PP and PPS show that the volume of the mesh decreases 
relatively to the control. Remember that those implants PP and PPS have increased, then we can understand the 
scavenging effect of heavy metals in these types of apatite implants. For cons, the cell volume of apatite implant capsule 
administered in the same decreased bone implanted in rats of the same group decreased significantly. Which explains 
that the capsule thereafter passing in urine and not stocked in the kidneys because the biochemical analysis renal function 
(creatinine) showed no nephrotoxicity. This phenomenon was not observed in the case of groups implanted pellets type 
PP and PPS, this is probably due to the physical aspect of implants (compacted powders). We can be explained that by 
the blood circulation, which has not a relatively significant quitter effect of the heavy metals. So, this is  not the case of 
implant apatite powder (capsule), where the departure of heavy metals is easy and will be therefore compensated by an 
excess migration of other metals to bone from implant. Finally, we can confirm that the capsule is considered a reliable 
sponge to retain the heavy metals and the impurities habitually located in living bone. These results are in good 
agreement with those obtained by infrared spectroscopy. 
5. Conclusion 
the apatite biomaterial capsule has less oxidative stress, does not disturb the balance or ferric ion balance, maintains 
phosphocalcic balance, and does not cause liver- kidney toxicity. By cons, other physical forms (PP and PPS) of the 
implant did not present these beneficial effects to the body. Also, the implantation technique with capsule presents more 
ion exchange in comparison with the groups of rats implanted by the same apatite biomaterial into pellets.  
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